New framework helps biomanufacturers’ interventions, eyeing quality, cost, and stability for two-step chromatography decisions.
After years of antifungal resistance increasingly making standard-of-care treatments less effective, F2G and Shionogi have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results